| Business Summary | | Charles
River
Laboratories
International,
Inc.
is
a
provider
of
critical
research
tools
and
integrated
support
services
that
enable
efficient
drug
discovery
and
development.
The
Company
provides
the
animal
research
models
required
in
research
and
development
for
new
drugs,
devices
and
therapies,
and
has
been
in
this
business
for
more
than
50
years.
Since
1992,
the
Company
has
built
upon
its
research
model
technologies
to
develop
a
broad
and
growing
portfolio
of
biomedical
products
and
services.
The
Company's
product
line
segments
are
research
models
and
biomedical
products
and
services. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Charles
River
Laboratories
is
a
provider
of
research
tools
and
integrated
support
services
that
enable
innovative
and
efficient
drug
discovery
and
development,
including
genetically
and
virally
defined
purpose-bred
rats
and
mice.
For
the
six
months
ended
6/30/01,
net
sales
rose
44%
to
$215.9
million.
Net
income
before
extraordinary
item
totaled
$17.8
million,
up
from
$8.6
million.
Results
reflect
growth
in
biomedical
products
and
services,
acquisitions
and
lower
interest
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| James Foster, 50 Chairman,
Pres, CEO | $1.1M | Thomas Ackerman, 46 Sr.
VP, CFO | 419K | Dennis Shaughnessy, 43 Sr.
VP, Corp. Devel., Gen. Counsel, Sec. | 446K | David Johst, 39 Sr.
VP of HR and Admin. | 394K | Real Renaud, 54 Sr.
VP and Gen. Mang., European and North American Animal Operations | 502K | Dollar
amounts are as of 25-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|